Quest Diagnostics (NYSE:DGX) reported on Thursday second quarter earnings that beat analysts' forecasts and revenue that topped expectations.
Quest Diagnostics announced earnings per share of $3.18 on revenue of $2.55B. Analysts polled by Investing.com anticipated EPS of $2.86 on revenue of $2.39B.
Quest Diagnostics shares are up 13.99% from the beginning of the year, still down 4.92% from its 52 week high of $142.80 set on May 10. They are under-performing the S&P 500 which is up 16.04% from the start of the year.
https://www.investing.com/news/quest-diagnostics-earnings-revenue-beat-in-q2-2565068
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.